跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-DULOXETINE
Authorized
STANDARD
TEVA-DULOXETINE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
64382d5461a59c83
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
64382d5461a59c83
Drug Approval Canada Name
TEVA-DULOXETINE
Product Name
TEVA-DULOXETINE
Status
Marketed
Status Date
2020-04-24
Original Market Date
2020-04-24
Din
02456761
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350002
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
64382d5461a59c83
Type
Standard
Back to Health Canada Approvals